KRX-123

N/A

Report date: 2023/06/14 09:12:10

Base Information

Drug NameKRX-123
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionPhosphotransferases inhibitors
TargetsPhosphotransferases
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKeryx Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A